Delivery Order SPE2DP20D0002-SPE2DP22F2113

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on January 18, 2023 through January 24, 2023. The place of performance will be Teva Pharmaceuticals' location in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The contract period of performance is from February 10, 2022 through March 1, 2022. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' location in Parsippany, New Jersey. The contract period of performance spans from December 6, 2022 through December 20, 2022. No subcontractors were identified.</p>

The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4 from February 22, 2023 through February 28, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. Teva Pharmaceuticals will serve as the prime contractor to supply the Adenovirus Type 4 to the Defense Logistics Agency Troop Support Medical. No subcontractors were...

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide adenovirus type 4. The place of performance for this contract is Teva Pharmaceuticals' location in Parsippany, New Jersey. The contract period of performance spans from February 10, 2022 through March 1, 2022. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' location in Parsippany, New Jersey. The contract period of performance spans from March 22, 2022 through March 29, 2022. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on May 17, 2023 through May 23, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from their location in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide adenovirus type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The period of performance is scheduled from September 13, 2022 through September 20, 2022. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $282,353.76 firm fixed price delivery order contract to provide adenovirus type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform the work in Parsippany, New Jersey from December 7, 2021 through December 14, 2021.</p>